A Placebo-Controlled, Randomized Trial of Mesenchymal Stem Cells in COPD
Background: COPD is a devastating disease affecting millions worldwide. As disease pathogenesis includes both chronic pulmonary and systemic inflammation, antiinflammatory effects of systemically administered mesenchymal stem cells (MSCs) may decrease…